Searched for
DIABETES IN AMERICA
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analysts- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...17 Jun, 2026, 03.08 PM IST
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...16 Jun, 2026, 06.27 PM IST
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...12 Jun, 2026, 12.25 PM IST
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...29 May, 2026, 05.30 AM IST
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...29 May, 2026, 12.57 AM IST
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...23 May, 2026, 10.24 PM IST
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...13 May, 2026, 01.18 PM IST
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...10 May, 2026, 08.50 AM IST
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...10 May, 2026, 12.18 AM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- International travel insurance: How to choose right cover with adequate medical protection, add-ons and claims supportMedical coverage, duration and geography, add-ons, and claims experience are some aspects one must keep in mind before selecting the intern...27 Apr, 2026, 06.01 PM IST
- New Study reveals nearly half of people with Diabetes remain undiagnosed, here’s how to detect earlyA new study published in The Lancet: Diabetes and Endocrinology offers one of the most extensive global evaluations of diabetes care, analy...21 Sep, 2025, 09.10 PM IST
- Catching heart disease in its quietest moments in Type 2 diabetesEarly detection of heart disease in Type 2 diabetes is crucial, as it often develops silently. Advanced tests like high-sensitivity blood w...27 Aug, 2025, 12.09 PM IST
- Americans' favourite comfort food they eat every day could spike diabetes by 20 percent: Harvard studyA Harvard study revealed that frequent consumption of French fries significantly elevates the risk of type 2 diabetes, while other potato p...24 Aug, 2025, 11.06 PM IST
- Lupin inks licensing deal to supply biosimilar ranibizumab in Latin AmericaLupin, an Indian drug maker, partners with SteinCares. The agreement focuses on ranibizumab's commercialisation. Latin America, excluding M...26 May, 2025, 02.24 PM IST
- Non-Covid deaths increased in people with diabetes, women, young affected more: Lancet StudyThe team of researchers, including those from the World Health Organization (WHO), looked at 138 studies - North America (39), Western Euro...24 Jan, 2024, 03.50 PM IST
- Keeros Foods plans to raise $4 million over next two yearsKeeros Foods, a maker of diabetes snacks, plans to expand its reach to Top 30 cities in India, in an effort to tap the country’s $600-milli...04 Mar, 2021, 07.29 PM IST
Load More
